The barriers to entry for the world’s highest-quality capital are officially coming down. SEBI has notified the final rules for its new “Single Window Automatic & Generalised Access for Trusted Foreign Investors” (SWAGAT-FI) framework, effective June 1, 2026. This move is set to streamline access for nearly two-thirds of foreign investors looking to deploy capital...
🌊 FLOODGATES OPEN: Global Equities See $45.6B Inflow as Investors Dump Cash
The “Wait and See” period is officially over. Global equity funds just logged their strongest weekly inflows in 3.5 months, absorbing a massive $45.59 billion in the week ending January 14. Investors are aggressively brushing aside geopolitical headlines to chase the momentum of a market hitting fresh record highs. 💸 THE GREAT ROTATION: The data...
🐂 MARKET RALLY: Tech Earnings & Geopolitical Cool-Down Spark Wall Street Rebound
The fear trade is out; the growth trade is back in. Wall Street bounced higher today as a “perfect storm” of positive catalysts—led by TSMC’s forecast-smashing earnings and fading war risks in the Middle East—pushed equities back toward record territory. 📱 THE TECH CATALYST: 🕊️ THE GEOPOLITICAL PIVOT: Safe havens are unwinding rapidly as the...
🏦 PRIME TIME: Hedge Fund Leverage Fuels Wall Street’s Record Earnings Engine
The “Smart Money” had a banner year in 2025, and Wall Street’s biggest banks are cashing the checks. As major banks report Q4 earnings, a clear theme has emerged: Prime Brokerage is the MVP. With multi-strategy hedge funds navigating volatility and leveraging up to chase AI-driven returns, the financing engines at JPMorgan, Goldman Sachs, and...
🫀 MEDTECH MEGA-DEAL: Boston Scientific Drops $14.5B to Acquire Penumbra
The 2026 healthcare M&A wave has officially begun. Boston Scientific (BSX) has agreed to acquire vascular tech leader Penumbra (PEN) in a deal valued at $14.5 billion. This is Boston’s second-largest acquisition ever, designed to fast-track its re-entry into the high-growth neurovascular market. 💰 THE DEAL METRICS: 🧠 THE “BOOMERANG” STRATEGY: This deal represents a...
🐂 GOLDMAN SACHS SURGE: Record Trading & 25% IB Jump Signal “Incredibly Constructive” 2026
The “King of Wall Street” is back on the throne. Goldman Sachs (GS) delivered a massive Q4 profit beat ($14.01 EPS vs $11.67 est), driven by record equity trading revenues and a resurgence in dealmaking. Shares climbed >3% as CEO David Solomon declared the environment “incredibly constructive” for 2026. 📊 THE EARNINGS BREAKDOWN: 🏛️ THE...
